TRIM21 and neoplasm: To elucidate the effect of TRIM21 on T-cell-mediated antitumour immunity, we performed gene set enrichment analysis (GSEA) and demonstrated that TRIM21-high tumours showed weak IFN responses, especially the type-I IFN response (Fig. 1d).